Infections Related Central Venous Catheters

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-11-30

Study Completion Date

2008-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to clarify the relationship between SIRS (Systemic inflammatory response syndrome) and the infection associated with the use of central venous catheters at Critical Care center in National Defense Medical College, Japan.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg

NCT01388686

Bacteremia

TERMINATED

Determinants of Vascular Leakage During Systemic Inflammatory Response Syndrome

NCT05663216

Systemic Inflammatory Response Syndrome

RECRUITING

Catheter Early Withdrawal or Maintenance in Sepsis or Septic Shock

NCT01947751

Catheter Related Infection

UNKNOWN NA

Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock

NCT04870892

Septic Shock

UNKNOWN

Vaccine Response in Patient With Sepsis

NCT04823039

Sepsis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The doctor would remove the inserted catheter from the patient, if the patient shows SIRS. At the same time, the tip of used catheter and blood from the patient are checked whether the pathogenic bacteria exists or not by general bacterial protocol and blood culture test on a routine application. Unfortunately, these tests not always clarified their cause of SIRS. Therefore we conduct this investigation to establish the useful protocol for pathogenic bacteria. We check the pathogenic bacteria not only tip but through the whole catheter in Central Venous Catheter using general bacterial protocol and SEM observation. Additionally, we compared that sputum, urine, skin and blood from the patient for bacteria check.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SIRS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Department of Traumatology and Critical Care Medicine, National Defense Medical College

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A patient has been inserted with central venous line over 24 hours.

Minimum Eligible Age

14 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

NDMC

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kahoko NISHIKAWA, PHD

Role: STUDY_DIRECTOR

National Defense Medical College

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Traumatology and Critical Care of Medicine

Tokorozawa, Saitama, Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NDMC-CV0001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Carotid Ultrasounds Measurements in Septic Shock

NCT05444621 UNKNOWN

Infected Elders in the Emergency Department: Outcomes and Processes of Care

NCT00591955 COMPLETED

Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis

NCT05681442 RECRUITING PHASE4

The Effect of Remote Ischemic Conditioning on the Microcirculation in Sepsis

NCT04644926 COMPLETED PHASE1/PHASE2

C-reactive Protein Information and Blood Cultures for Emergency Department Patients With Sepsis

NCT03714841 UNKNOWN NA

Causes and Factors Associated With Outcomes in Community-acquired Sepsis and Severe Sepsis in Northeast Thailand

NCT02217592 COMPLETED

Ultrasound-guided Blood Sampling Drawing for Microbiological Analysis in the Critically Ill

NCT06156072 NOT_YET_RECRUITING

Preemptive Resuscitation for Eradication of Septic Shock

NCT01449721 COMPLETED NA

The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis

NCT03314831 COMPLETED

Microcirculatory Oxygen Uptake in Sepsis

NCT02430142 COMPLETED

Effects of Endotoxin Absorption and Cytokine Removal Hemofilter on Severe Septic Shock

NCT03974386 COMPLETED NA

Effect of Different Strategies for Titrating a High MAP on Microcirculation

NCT02085291 COMPLETED PHASE4

Effects of Viral Reactivation on Outcomes of Brain-injured Patients ( IBIS-VIRUS)

NCT02003196 COMPLETED

Metabolism of Branched-chain Amino Acids in Monocyte/Macrophage During Sepsis

NCT03842371 UNKNOWN

Safety and Efficiency of Combined Extracorporeal Blood Purification in Neurosurgical ICU. Prospective RCT

NCT04152174 UNKNOWN NA

Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections

NCT04395911 COMPLETED NA

The Changes of CD4+T Lymphocyte Subsets in Septic Patients

NCT01494389 UNKNOWN

The Th17/Treg Cells and IL-23/IL-17 Axis and Early Enteral Nutrition in Sepsis

NCT03385850 COMPLETED NA

Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic Shock

NCT05813951 UNKNOWN NA

Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis

NCT04644302 COMPLETED

Septic Shock-induced Immunosuppression

NCT04067674 RECRUITING

Cytokine Hemadsorption in Covid 19 Patients With Bacterial Sepsis

NCT04920851 UNKNOWN

In Vivo Antibiotics Removal During Hemoadsorption Cartridges and Continuous Renal Replacement Therapy in the Intensive Care Unit

NCT07230041 RECRUITING

Sepsis Early EvaluatioN Through Rapid Ultrasound and veNous Gas Analysis

NCT05787184 UNKNOWN

Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients

NCT06904001 ENROLLING_BY_INVITATION